These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15126841)
41. Endorectal color Doppler imaging of primary and recurrent rectal wall tumors: preliminary experience. Sudakoff GS; Gasparaitis A; Michelassi F; Hurst R; Hoffmann K; Hackworth C AJR Am J Roentgenol; 1996 Jan; 166(1):55-61. PubMed ID: 8571905 [TBL] [Abstract][Full Text] [Related]
42. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results. Jung EM; Wiggermann P; Greis C; Eder F; Ehrich J; Jung W; Schreyer AG; Stroszczynski C; Ganzer R Clin Hemorheol Microcirc; 2012; 52(2-4):167-77. PubMed ID: 22975940 [TBL] [Abstract][Full Text] [Related]
43. Additional Targeted Biopsy in Clinically Suspected Prostate Cancer: Prospective Randomized Comparison between Contrast-Enhanced Ultrasound and Sonoelastography Guidance. Koh J; Jung DC; Oh YT; Yoo MG; Noh S; Han KH; Rha KH; Choi YD; Hong SJ Ultrasound Med Biol; 2015 Nov; 41(11):2836-41. PubMed ID: 26298036 [TBL] [Abstract][Full Text] [Related]
44. [Color Doppler echography in the diagnosis of nonspecific granulomatous prostatis: personal experience]. Vespasiani G; Bitelli M; Mele GO; Torelli F; Di Stasi SM; Valitutti M; Virgili G Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):57-60. PubMed ID: 9162375 [TBL] [Abstract][Full Text] [Related]
45. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Eckersley RJ; Sedelaar JP; Blomley MJ; Wijkstra H; deSouza NM; Cosgrove DO; de la Rosette JJ Prostate; 2002 Jun; 51(4):256-67. PubMed ID: 11987154 [TBL] [Abstract][Full Text] [Related]
46. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection. Mitterberger M; Horninger W; Pelzer A; Strasser H; Bartsch G; Moser P; Halpern EJ; Gradl J; Aigner F; Pallwein L; Frauscher F Prostate; 2007 Oct; 67(14):1537-42. PubMed ID: 17705242 [TBL] [Abstract][Full Text] [Related]
47. Role of colour Doppler imaging in detecting prostate cancer. Sen J; Choudhary L; Marwah S; Godara R; Marwah N; Sen R Asian J Surg; 2008 Jan; 31(1):16-9. PubMed ID: 18334464 [TBL] [Abstract][Full Text] [Related]
48. [Contrast media in ultrasonography. Prostate]. Pavlica P; Barozzi L; Veneziano S Radiol Med; 1998 May; 95(5 Suppl 1):71-4. PubMed ID: 9687908 [No Abstract] [Full Text] [Related]
49. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies. Kravchick S; Cytron S; Peled R; London D; Sibi Y; Ben-Dor D Urology; 2004 Feb; 63(2):301-5. PubMed ID: 14972476 [TBL] [Abstract][Full Text] [Related]
50. Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer. Strigari L; Marsella A; Canitano S; Gomellini S; Arcangeli S; Genovese E; Saracino B; Petrongari MG; Sentinelli S; Crecco M; Benassi M; Arcangeli G Med Phys; 2008 Nov; 35(11):4793-9. PubMed ID: 19070211 [TBL] [Abstract][Full Text] [Related]
51. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer. Morelli G; Pagni R; Mariani C; Minervini R; Morelli A; Gori F; Ferdeghini EM; Paterni M; Mauro E; Guidi E; Armillotta N; Canale D; Vitti P; Caramella D; Minervini A J Urol; 2011 Jun; 185(6):2126-31. PubMed ID: 21496853 [TBL] [Abstract][Full Text] [Related]
53. Editorial comment to standard and saturation transrectal prostate biopsy techniques are equally accurate among prostate cancer active surveillance candidates. Lee M Int J Urol; 2013 Sep; 20(9):864-5. PubMed ID: 23294147 [No Abstract] [Full Text] [Related]
54. Multiparametric Sonography of Hematologic Malignancies of the Testis: Grayscale, Color Doppler, and Contrast-Enhanced Ultrasound and Strain Elastographic Appearances With Histologic Correlation. Kachramanoglou C; Rafailidis V; Philippidou M; Bertolotto M; Huang DY; Deganello A; Sellars ME; Sidhu PS J Ultrasound Med; 2017 Feb; 36(2):409-420. PubMed ID: 28032907 [TBL] [Abstract][Full Text] [Related]
55. [Transrectal ultrasonography in the early diagnosis of prostate carcinoma: use of a new ultrasonography technique with endorectal probe]. Sperandeo M; Sperandeo G; Varriale A; La Viola M; Perta A; Morcaldi M; Dimitri L; Camagna A Arch Ital Urol Androl; 2000 Dec; 72(4):200-4. PubMed ID: 11221037 [TBL] [Abstract][Full Text] [Related]
56. The value of contrast enhanced power Doppler ultrasonography in differentiating hypoehoic lesions in the peripheral zone of prostate. Karaman CZ; Unsal A; Akdilli A; Taşkin F; Erol H Eur J Radiol; 2005 Apr; 54(1):148-55. PubMed ID: 15797304 [TBL] [Abstract][Full Text] [Related]
57. Re: Editorial: transrectal ultrasound guided prostate biopsy-defining a new standard. Lehmann K J Urol; 2000 Jul; 164(1):129. PubMed ID: 10840467 [No Abstract] [Full Text] [Related]
58. Color Doppler sonography of the prostate. Ismail M; Gomella LG; Alexander AA Tech Urol; 1997; 3(3):140-6. PubMed ID: 9422445 [TBL] [Abstract][Full Text] [Related]
59. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Cho JY; Kim SH; Lee SE Eur Urol; 2000 Apr; 37(4):443-8. PubMed ID: 10765075 [TBL] [Abstract][Full Text] [Related]
60. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Trabulsi EJ; Sackett D; Gomella LG; Halpern EJ Urology; 2010 Nov; 76(5):1025-33. PubMed ID: 20719368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]